Highlights
A collection of news and information related to AstraZeneca Plc published by this site and its partners.
Displaying items 1-12 of 54
» View latimes.com items only
1
2
3
4
5
•
Next >
-
More data needed on experimental drug for diabetes: study
Diabetes affects more than 25 million Americans. New medications and strategies to treat the disease are greatly needed. But the jury is still out on the experimental medication dapagliflozin. The medication looks to have significant benefits and risks,...
Tags: Food and Drug Administration, Placebo, Human Body, Pharmaceuticals, Health
-
Propofol, the drug that killed Michael Jackson, isn't 'dangerous'
Readers' Representative JournalIn this week’s coverage of the trial of Michael Jackson’s personal physician, Dr. Conrad Murray, articles have been consistent in describing the drug that killed the pop star: Tuesday: “the dangerous surgical anesthetic propofol”... -
Party time again: Michelle Obama explains the Angela Merkel state dinner for you guys without invites
Top of the TicketGermany's leader is feted at the Obamas' fourth White House State Dinner. With full guest list.... -
AstraZeneca to pay $68.5 million in Seroquel settlement
Money & CompanyCalifornia Atty. Gen. Kamala D. Harris on Thursday announced a $68.5-million multistate settlement with AstraZeneca Pharmaceuticals after the states sued the company for allegedly using unfair and deceptive marketing practices for its antipsychotic drug... -
Statins for all?
Los Angeles Times Staff WriterShould statin drugs be put in the water, or what? More than 13 million Americans are taking these medications to lower their cholesterol and hopefully stave off heart disease -- a job the drugs appear to excel at. Statins can lower "bad" LDL...Tags: Multiple Sclerosis, Brain, Lou Gehrig, Harvard Medical School, University of Texas at Austin
-
FDA panel recommends wider use for cholesterol-lowering drug Crestor
Booster ShotsA Food and Drug Administration advisory panel recommended today that drug-maker AstraZeneca be allowed to expand the labeling on its cholesterol-lowering drug Crestor to include some people who do not have high cholesterol levels. That could allow as many... -
Use of atypical antipsychotics for lesser disorders is gaining ground, despite safety concerns
Los Angeles Times Staff WriterAbout a year ago, patients began trooping into the office of UCLA psychiatrist Andrew Leuchter, asking whether an antipsychotic drug called Abilify "might be right for them." Few appeared to be delusional, plagued by hallucinations or suffering fearsome...Tags: Education, Companies and Corporations, Brain, U.S. Department of Justice, Prescription Drugs
-
A bitter pill for Big Pharma
The strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth is finally starting to betray it. Beginning in just a few weeks, and continuing over the next several years, some of the biggest-selling and most...Tags: Companies and Corporations, Fosamax (drug), Science and Technology, Marketing, Prescription Drugs
-
Three Researchers in NIH Controversy Are Leaving
Times Staff WriterThree senior researchers at the center of a controversy at the National Institutes of Health over moonlighting for the pharmaceutical industry are leaving the government, officials said. The departures come at a time when the NIH is implementing...Tags: Companies and Corporations, Science and Technology, Health Organizations, Science, Biotechnology
-
The National Institutes of Health: Public Servant or Private Marketer?
Times Staff WriterFor 15 million Americans, it is a daily ritual: gulping down a pill to reduce cholesterol. They do it because their doctors tell them to. Their doctors, in turn, rely on recommendations from the National Institutes of Health and its scientists, such as...Tags: Censorship, Science and Technology, Joe Barton, Prescription Drugs, Civil Rights
-
Greenspan Worried About Trade Deficit
Times Staff WriterWall Street stock swooned today after Federal Reserve Chairman Alan Greenspan expressed concerns about the chronic and growing U.S. trade deficit and its impact on the value of the U.S. dollar and interest rates. The Dow Jones industrial average lost...Tags: Market and Exchange, Foreign Exchange Market, Abbott Laboratories, Federal Reserve, Budgets and Budgeting
-
State biotech firms hope Congress will act
A proposal to speed the approval of new prescription drugs has patient advocates and biotech firms — including many based in Maryland — hoping that Congress will deliver a rare dose of bipartisanship this year.
Lawmakers are proposing a 6...Tags: Companies and Corporations, Maryland Department of Business and Economic Development, Instrument Engineering, Science and Technology, Prescription Drugs
Mar 19, 2012
|Story| Los Angeles Times
Sep 30, 2011
| Los Angeles Times
Jun 7, 2011
| Los Angeles Times
Mar 10, 2011
| Los Angeles Times
Dec 22, 2008
|Story| Los Angeles Times
Dec 15, 2009
| Los Angeles Times
Apr 13, 2009
|Story| Los Angeles Times
Jan 27, 2008
|Story| Los Angeles Times
Mar 10, 2005
|Story| Los Angeles Times
Dec 22, 2004
|Story| Los Angeles Times
Nov 19, 2004
|Story| Los Angeles Times
May 5, 2012
|Story| Baltimore Sun
Original site for AstraZeneca Plc topic gallery.
